Wordt geladen...
Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation
Acute myeloid leukemia (AML) is a malignancy of uncontrolled proliferation of immature myeloid blasts characterized by clonal evolution and genetic heterogeneity. FMS-like tyrosine kinase 3 (FLT3) mutations occur in up to a third of AML cases and are associated with highly proliferative disease, sho...
Bewaard in:
| Gepubliceerd in: | Ther Adv Hematol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7271272/ https://ncbi.nlm.nih.gov/pubmed/32547718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720930614 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|